Hyzaar is a prescription medicine used to treat high blood pressure. This selection from the eMedTV archives explains how this drug works and offers detailed information on the effects, dosages, and potential side effects of Hyzaar.
This eMedTV segment lists several of the most common Hyzaar side effects, including low potassium levels, an infection (such as the common cold or flu), and dizziness. This article also talks about the more severe and rare side effects of this drug.
A healthcare provider may prescribe Hyzaar to lower high blood pressure in adults. This eMedTV page explains that the uses of Hyzaar will not cure high blood pressure, but it can help decrease the risks that occur with long-term high blood pressure.
As this eMedTV article explains, the recommended Hyzaar dosage for people with high blood pressure will vary between Hyzaar 50 mg/12.5 mg and Hyzaar 100 mg/25 mg once a day. This resource also explores general Hyzaar dosing guidelines.
This section of the eMedTV archives takes an in-depth look at potential Hyzaar drug interactions with medications such as narcotics, insulin, and diuretics. This page also explores how these drug interactions can potentially affect your health.
This eMedTV page outlines Hyzaar precautions and warnings -- for example, prior to taking Hyzaar, you should tell your doctor if you have heart disease, asthma, or allergies. This Web page also explains who should avoid taking this medication.
As this eMedTV Web page explains, Hyzaar poses some health risks to an unborn child. This article offers an overview of Hyzaar and pregnancy, including information on the FDA's pregnancy category system.
It is possible to overdose on Hyzaar. As this portion of the eMedTV library explains, you should seek medical attention immediately if you experience Hyzaar overdose symptoms, such as vomiting, dizziness, or a decrease in urine output.
There is currently no generic Hyzaar available, as Hyzaar is still protected by a patent. This eMedTV page explains that a generic form may become available as early as 2009. Until then, be advised of any drugs claiming to be a generic version.
